Treatment of dry eye by autologous serum application in Sjögren's syndrome. - Wikidata - awgldk - TriplyDB

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

http://www.wikidata.org/entity/Q35309629

about

Autologous serum eye drops for dry eye Autologous serum eye drops for dry eye syndrome Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome Lacritin, a novel human tear glycoprotein, promotes sustained basal tearing and is well tolerated.Dry eye: an inflammatory ocular disease The ocular surface chemical burns Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies Selenoprotein P controls oxidative stress in cornea Autologous serum eye drops for dry eye.Use of umbilical cord serum in ophthalmology.Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.Application of umbilical cord serum eyedrops after laser epithelial keratomileusis.Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.Aging: a predisposition to dry eyes.Dry eye disease: A review of diagnostic approaches and treatments Effects of amniotic membrane suspension in the rat alkali burn model.New treatment of dry eye: the effect of calcium ointment through eyelid skin delivery Autologous Serum Eye Drops Accelerate Epithelial Healing After LASEK.Proinflammatory gene polymorphisms are potentially associated with Korean non-Sjogren dry eye patients.Improvement of corneal fluorescein staining in post cataract surgery of diabetic patients by an oral aldose reductase inhibitor, ONO-2235.Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device.Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.Autologous serum eye drops for ocular surface disorders.Iodide iontophoresis as a treatment for dry eye syndrome.JBP485 promotes tear and mucin secretion in ocular surface epithelia.Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops.A novel use of amniotic membrane in the management of tube exposure following glaucoma tube shunt surgery The use of autologous serum tears in persistent corneal epithelial defects.Albumin as a tear supplement in the treatment of severe dry eye.Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis.The use of autologous serum for the treatment of ocular surface disease at a Swedish tertiary referral center Still confused about rose bengal?The Impact of Visual Guided Order Picking on Ocular Comfort, Ocular Surface and Tear Function Bioengineered Lacrimal Gland Organ Regeneration in Vivo.Human albumin eye drops as a therapeutic option for the management of keratoconjunctivitis sicca secondary to chronic graft-versus-host disease after stem-cell allografting.Current concepts in ocular surface reconstruction.Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.Comparison of corneal epitheliotrophic capacities among human platelet lysates and other blood derivatives Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease Autologous Platelet-rich Plasma Eye Drops in the Treatment of Recurrent Corneal Erosions.

P2860

Q24200233-AD149065-0B65-4EC9-A71B-C6E7297CED24 Q24234791-35FE3AA2-BFC9-4B32-9771-30578F717719 Q24282614-D563B99C-FE92-46D1-B792-1ED3DC364E32 Q24635929-DF88615E-807E-477F-9C37-EE56A573F291 Q26852044-B8CED60B-4EC4-4108-BFD5-3E5F1027F0CD Q27023821-D8A73406-4BFB-4D9E-9649-E3B47976FF37 Q28360278-362A1519-331B-4964-85A3-73AF388C9008 Q28748239-04A16AD0-1863-4931-9DFA-E857D471C0E8 Q30235522-05177876-B25F-4F90-9C35-6A44B1280BCB Q30421187-A3092E88-A3BD-4A77-BE8F-67B1CAB5677D Q30432843-2988E7F1-8A7B-4620-95CE-E0DC99CE0B70 Q31096052-16BEB6D0-1E21-461D-8328-596F1B052CD1 Q34028408-B9AB86DB-0C15-4E35-8E12-8DA5FBC54A8B Q34114336-845C3E52-9E25-44B2-846B-CFA7AB256DE9 Q34273384-766574A3-BFF5-4439-8CED-003F2E2A2E07 Q34564100-3806B36D-2C21-4631-908F-32E1CBFFEEFB Q35310464-7EF023A6-717A-419A-903B-BBFE051F2A6B Q35547147-B71DFC7E-E60A-4EA7-A195-6FF195FF4793 Q35575095-FAB43201-44A6-45EB-B874-FF63726B9310 Q35589959-B8565C8F-FDAE-498F-ADE1-5DD6CDED8AAB Q35590257-77CA6C87-9334-476A-8475-F88104E08DC7 Q35592019-9BBF6593-CF46-4761-B916-D78FCAEC4CE2 Q35592577-76A18F36-04F7-4BC3-9FE4-0EA43734B0FF Q35592791-1CC14139-25FC-455E-B0D9-CA96053669CB Q35633676-303AFD2F-C0CF-4459-9375-B7D0C58D7C46 Q35699085-F333A806-07C0-4323-AED7-1A9AF253E33D Q35761678-F0D1BB4E-07F9-4AFF-ADFA-1C97B2628056 Q35797113-CA941174-1599-4236-8A5B-A66104829BAD Q35895180-54E88348-D945-4C44-93C4-1118884CC470 Q35952534-E1E3AD80-3F5B-46CC-913F-3E2BDCBB1125 Q35978885-9551F713-984E-464D-BD8B-8A206C60C399 Q35980008-1736FF84-8A34-48C5-8B05-310A299FBDC1 Q36055391-B57537CB-E0E3-4297-BBE2-9470F5195FCD Q36138820-524CB1B5-B2FE-4D63-907D-4E4E10FD4636 Q36169872-FBBD13F2-6F47-4CBA-B95D-9C711A920D2C Q36195255-B128B1A3-080D-4F4F-BEE0-5192609863FE Q36252489-23723B65-84EA-486C-989E-E42FE4B704CC Q36267618-6B02F100-FD3E-44DC-AE7F-6A80243731C2 Q36569538-59DE7987-46BC-4053-83DC-3F4265DA5E6B Q36764408-D229D8E2-5F11-45ED-B06C-E6F4C6E3C935

P2860

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

http://www.wikidata.org/entity/Q35309629

description

1999 nî lūn-bûn

@nan

1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@ast

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@en

type

label

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@ast

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@en

prefLabel

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@ast

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@en

P1433

Q35309629-CCB1CE95-E919-4890-AB40-544B26C8AC4C

P1476

Q35309629-455C47F6-A879-4459-A831-0D77B1CCD2AF

P2093

Q35309629-01FE3901-9F23-498D-B063-6E2B21C42CC5

Q35309629-080066BC-7E41-46BD-8635-0F47E7F2C6B3

Q35309629-0FF23C4A-C453-4297-8D94-080B2A043108

Q35309629-1605E965-A408-44E7-B9FE-DB8869706718

Q35309629-2EE09438-DFC6-44C4-A99F-0FECD00D2A2F

Q35309629-647F971C-FEAB-4B3A-875A-2AEE46FE0377

Q35309629-98F604A3-4253-440E-B36C-9F7C9231CB9C

P2860

Q35309629-06DE3E96-1DD8-4121-912B-51FA0F399C7C

Q35309629-0EBB8DD6-3676-4740-A9A0-C6AD14D6B597

Q35309629-1A1111F3-DA3A-4B7E-BE2E-761ADAE80D67

Q35309629-1B715143-E8A5-4BCB-A6D0-E9B61F0CED91

Q35309629-32D5A6EA-04F6-44A2-903A-549918747FF8

Q35309629-3A61495F-8202-4627-9C40-C47D6DD8A484

Q35309629-42B11E4E-C7DE-4FEC-B6EA-F1AB1B1A4F0B

Q35309629-94C9777E-C333-4D9D-A00F-D2D08F46E57F

Q35309629-9B9815BF-2A4B-46FA-B9D4-903022913650

Q35309629-B889F39C-7FE3-4ACF-914C-F4D442431082

P304

Q35309629-4C8A6356-05BE-4ED7-BFF4-30A751F68780

P31

Q35309629-BB0A0B83-9A6B-4BEA-8D76-BA12337437C4

P356

Q35309629-D45C481A-2BC6-4A06-956F-5D3CA551B3CA

P407

Q35309629-E53641F4-FF7F-4BCB-AC38-E581970D5C8E

P433

Q35309629-CC7C4B13-CE22-4A07-A71F-E7B51D4E434F

P478

Q35309629-D47AF89C-8E19-4A8D-951E-0F45E9B44432

P577

Q35309629-E730A35F-3DA5-4DA9-84A6-6A33CE8FCA7A

P5875

Q35309629-73FF73F3-00E5-482A-AF14-2098E7E0F2D6

P698

Q35309629-9A7ACB02-24D0-434E-AD94-87E46101B34D

P932

Q35309629-1498A9F2-9B12-4AED-B802-D0C0A6EB97F7

P356

P1433

British Journal of Ophthalmology

P1476

Treatment of dry eye by autologous serum application in Sjögren's syndrome.

@en

P2093

Fujita H

http://www.w3.org/2001/XMLSchema#string

Goto E

http://www.w3.org/2001/XMLSchema#string

Inoue H

http://www.w3.org/2001/XMLSchema#string

Ono M

http://www.w3.org/2001/XMLSchema#string

Saito I

http://www.w3.org/2001/XMLSchema#string

Shimmura S

http://www.w3.org/2001/XMLSchema#string

Tsubota K

http://www.w3.org/2001/XMLSchema#string

P2860

Excimer laser photorefractive keratectomy for patients with contact lens intolerance caused by dry eye.

Spectacle side panels and moist inserts for the treatment of dry-eye patients.

Recent developments in dry eye management.

The dry eye: its mechanisms and therapy, with evidence that contact lens is a cause.

Criteria for diagnosis of Sjögren's syndrome.

Epidermal growth factor (urogastrone) in human fluids: size heterogeneity.

New approaches to dry-eye therapy.

Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.

Transforming growth factor beta-1 and beta-2 in human tear fluid.

Conjunctival transdifferentiation induced by systemic vitamin A deficiency in vascularized rabbit corneas.

P304

390-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.83.4.390

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234032458

http://www.w3.org/2001/XMLSchema#string

P698

10434857

http://www.w3.org/2001/XMLSchema#string

P932

1723012

http://www.w3.org/2001/XMLSchema#string